{"id":"NCT01102803","sponsor":"Southern Methodist University","briefTitle":"D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia","officialTitle":"Evaluation of the Effects of Post-Session Administration of D-cycloserine On Exposure Therapy Outcomes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-04","primaryCompletion":"2011-07","completion":"2011-07","firstPosted":"2010-04-13","resultsPosted":"2013-02-21","lastUpdate":"2013-02-21"},"enrollment":40,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Phobic Disorders"],"interventions":[{"type":"BEHAVIORAL","name":"Individual Cognitive Behavioral Therapy (CBT)","otherNames":["CBT","DCS"]},{"type":"DRUG","name":"D-Cycloserine","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sugar Pill","type":"PLACEBO_COMPARATOR"},{"label":"D-Cycloserine","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to investigate the utility of post-session administration of D-cycloserine to enhance fear extinction in a sample of people with acrophobia who will be treated with CBT.","primaryOutcome":{"measure":"Acrophobia Questionnaire With Avoidance (AAVQ)","timeFrame":"2 months","effectByArm":[{"arm":"DCS+CBT Treatment","deltaMin":9,"sd":7.41},{"arm":"Placebo+CBT Treatment","deltaMin":12.38,"sd":9.72}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["23332511","23098672"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":29},"commonTop":[]}}